ArticleJournal of medicinal chemistry2019

Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity.

Ellen Watts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.